Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

TAKEDA PHARMACEUTICAL CO LTD (TAK)

  • Business News
  • Aug. 27, 2026, 12:27 UTC
  • 0
  • 1 comments

Clinical trial NCT04464200 updates: 1. completion date: 2026-07-01 → 2027-07-01 2. primary completion date: 2026-07-01 → 2027-07-01

Market reaction Comment Full text

AMGEN INC (AMGN)

  • Business News
  • Aug. 27, 2026, 12:27 UTC
  • 0
  • 1 comments

Clinical trial NCT07222553: start date: 2026-04-03 → 2026-10-31.

Market reaction Comment Full text

GE HEALTHCARE TECHNOLOGIES INC. (GEHC)

  • Business News
  • Aug. 27, 2026, 12:27 UTC
  • 0
  • 1 comments

Clinical trial NCT06934096 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-04-15 → 2026-01-08 3. completion date: 2026-05-12 → 2027-01-31 4. primary completion date: 2026-04-21 → 2027-01-07

Market reaction Comment Full text

ASTRAZENECA PLC (AZN)

  • Business News
  • Aug. 27, 2026, 12:27 UTC
  • 0
  • 1 comments

Clinical trial NCT06681324: primary completion date: 2026-08-20 → 2026-08-10.

Market reaction Comment Full text

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)

  • Business News
  • Aug. 27, 2026, 12:27 UTC
  • 0
  • 1 comments

Clinical trial NCT07647510: start date: 2026-07-01 → 2026-06-29.

Market reaction Comment Full text

JAZZ PHARMACEUTICALS PLC (JAZZ)

  • Business News
  • Aug. 27, 2026, 12:27 UTC
  • 0
  • 1 comments

Clinical trial NCT05875974: enrollment: 207 → 199 participants.

Market reaction Comment Full text

MEDTRONIC PLC (MDT)

  • Business News
  • Aug. 27, 2026, 12:27 UTC
  • 0
  • 1 comments

Clinical trial NCT07585968 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-08-17

Market reaction Comment Full text

CITIGROUP INC (C)

  • SEC News
  • Aug. 27, 2026, 12:27 UTC
  • 0
  • 0 comments

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0001918704-26-025051 <b>Size:</b> 828 KB

Comment Full text

JPMORGAN CHASE & CO (JPM)

  • SEC News
  • Aug. 27, 2026, 12:27 UTC
  • 0
  • 0 comments

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0001213900-26-094226 <b>Size:</b> 2 MB

Comment Full text

BARINGS GLOBAL SHORT DURATION HIGH YIELD FUND (BGH)

  • SEC News
  • Aug. 27, 2026, 12:27 UTC
  • 0
  • 0 comments

New Form NPORT-P - BARINGS GLOBAL SHORT DURATION HIGH YIELD FUND <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0001193125-26-370195 <b>Size:</b> 284 KB

Comment Full text

MESHEK ENERGY-RENEWABLE ENERGIES LTD (MSKE)

  • Business News
  • Aug. 27, 2026, 12:27 UTC
  • 0
  • 1 comments

Eshkol Avshal Project – Execution of first withdrawal under the senior debt agreement and repayment of loans

Market reaction Comment Full text

EDIBLE GARDEN AG INC (EDBL)

  • Business News
  • Aug. 27, 2026, 12:27 UTC
  • 0
  • 1 comments

Edible Garden Awarded New Target Fresh Herb Program for Peak Holiday Season

Market reaction Comment Full text

INNOVATION PHARMACEUTICALS INC. (IPIX)

  • Business News
  • Aug. 27, 2026, 12:25 UTC
  • 0
  • 1 comments

Clinical trial NCT06321575 updates: 1. collaborators added: Bright Research, Inc. 2. collaborators removed: Bright Research Partners

Market reaction Comment Full text

KARYOPHARM THERAPEUTICS INC. (KPTI)

  • Business News
  • Aug. 27, 2026, 12:25 UTC
  • 0
  • 1 comments

Clinical trial NCT05611931 updates: 1. collaborators added: Hellenic Cooperative Oncology Group 2. collaborators removed: Hellenic Cooperative Oncology Group (HeCOG)

Market reaction Comment Full text

KURA ONCOLOGY, INC. (KURA)

  • Business News
  • Aug. 27, 2026, 12:25 UTC
  • 0
  • 1 comments

Clinical trial NCT06930352 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-09-10 → 2026-10-01

Market reaction Comment Full text
  • Previous
  • 1434
  • 1435
  • 1436
  • 1437
  • 1438
  • Next

Search

News categories

  • Technical Exchange News(14740)
  • Event(6229)
  • SEC News(396208)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(241579)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin